Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Primaa

Primaa
2018 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.2M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of a medical diagnostic software intended to assist in the pathology process. The company specializes in developing AI-based software tools to help in the detection of cancer by digitizing the slides and collecting images in a database, enabling clients to digitally identify tissue damage issues and form a diagnosis.

Formerly Known As
Kee Lab
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Primary Office
  • 96 bis Boulevard Raspail
  • 75006 Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Primaa’s full profile, request a free trial.

Primaa Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 11-Oct-2019 $2.2M 00.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Oct-2019 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Primaa Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
50 Partners Accelerator/Incubator Minority 000 0000 000000 0
Angels Santé Angel Group Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Entrepreneurs Investis (VC) Venture Capital Minority 000 0000 000000 0
Agoranov Accelerator/Incubator Minority 000 0000 000000 0

Primaa Executive Team (3)

Name Title Board
Seat
Contact
Info
Fanny Sockeel Co-Founder and Chief Executive Officer
Stéphane Sockeel Co-Founder and Chief Technology Officer
Marie Sockeel Co-Founder and Medical Advisor